Citadel Advisors - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,649
+58.4%
23,143
+126.7%
0.00%
Q2 2023$24,397
-83.2%
10,208
-78.2%
0.00%
Q1 2023$145,349
+231.8%
46,887
+186.8%
0.00%
Q4 2022$43,812
-91.3%
16,348
-90.4%
0.00%
Q3 2022$505,000
-29.0%
170,522
-29.7%
0.00%
Q2 2022$711,000
-65.8%
242,571
-40.3%
0.00%
Q1 2022$2,076,000
-28.2%
406,248
-5.2%
0.00%
-100.0%
Q4 2021$2,892,000
+20.6%
428,366
+23.7%
0.00%
Q3 2021$2,398,000
-30.3%
346,431
-2.0%
0.00%
-100.0%
Q2 2021$3,441,000
-9.5%
353,321
+46.3%
0.00%0.0%
Q1 2021$3,801,000241,5140.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,208,472$64,752,00013.08%
Ikarian Capital, LLC 527,964$15,480,0001.23%
Abingworth LLP 53,612$3,001,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 432,670$12,686,0000.37%
Eversept Partners, LP 46,310$1,357,8090.19%
BOOTHBAY FUND MANAGEMENT, LLC 44,024$1,291,0000.09%
KNOTT DAVID M 3,835$112,0000.06%
Baker Brothers Advisors 199,671$5,854,0000.03%
HRT FINANCIAL LP 7,339$215,0000.01%
Renaissance Technologies 29,986$879,0000.00%
View complete list of PROTARA THERAPEUTICS INC shareholders